Before we jump into today’s post, we want to thank Immunio for expressing interest in licensing this content. This type of support enables us to bring quality research to you, free of charge. If you are interested in licensing this Securosis research as well, please let us know. And we want to thank all of you who have been commenting throughout this series – we have received many good comments and questions. We have in fact edited most of the posts to integrate your feedback, and added new sections to address your questions. This research is certainly better for it!